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http:WHAT THIS PAPER ADDS
In order to enhance the midterm results of EVAR, and especially the occurrence of type 1 endoleaks, this study
shows that endovascular therapists should always perform endograft sizing utilizing 3D workstations.Objectives: To evaluate the inﬂuence of planning endovascular aneurysm repair (EVAR) with a three-dimensional
(3D) workstation on early and midterm outcomes.
Methods: All patients undergoing infrarenal EVAR performed between 2006 and 2009 at our institution were
included in the current study. Prior to 2008 (group 1), endograft sizing was performed by interrogation of
computed tomography angiography axial images. After 2008 (group 2), endograft sizing was routinely performed
using a 3D workstation (Aquarius, Terarecon), allowing for multiplanar reconstruction and centerline analysis.
Pre-, peri-, postoperative, and follow-up data were prospectively entered in an electronic database. All
postoperative complications and subsequent secondary interventions depicted during the 2-year period
following EVAR were compared. Secondary intervention and mortality rates were deﬁned at 2 years and
compared. Freedom from secondary intervention and overall survival rates were calculated using the Kaplane
Meier method during follow-up and compared by log-rank test.
Results: A total of 295 patients (149 patients in group 1 and 146 patients in group 2) were included. All patients
had completed a minimum of 2 years of follow-up. During this 2-year period following EVAR, the type 1 endoleak
rate was 8.7% in group 1 and 1.4% in group 2 (p ¼ .004) respectively. Secondary intervention rates related to
type 1 endoleak was 5.4% in group 1 and 0 in group 2 (p < .001). No difference was observed regarding all-cause
mortality, aneurysm-related death, and freedom from secondary intervention rates during follow-up.
Conclusion: The routine use of 3D workstations for EVAR planning signiﬁcantly reduces the rate of type 1
endoleaks and, therefore, the rate of related secondary interventions.
 2013 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
Article history: Received 18 April 2013, Accepted 29 July 2013, Available online 22 August 2013
Keywords: Endograft, Planning, Three-dimensional workstationINTRODUCTION
Endovascular treatment of abdominal aortic aneurysm
(EVAR) was introduced 20 years ago.1 Recent publications
have reported reductions in early mortality rates.2,3 It is
generally agreed that the major drawback of EVAR is the
high secondary intervention rate required to correct
endograft-related complications.2 The postoperative pres-
ence of type 1 or 3 endoleaks (immediate or late), graft limb
thrombosis, aneurysm expansion, aneurysm rupture, or
conversion to open repair is deﬁned as clinical failure
after EVAR.4 Precise preoperative study of the aortic anat-
omy based on high-quality preoperative computerized to-
mography angiography scans (CTA) is required to determineTo access continuing medical education questions on this pa-
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and plan the procedure. Endograft sizing software
including three-dimensional (3D) reconstructions of the
preoperative computed tomography angiography (CTA)
and stretch reconstructions perpendicular to a semi-
automatically generated centerline are now widely avail-
able for endovascular surgeons (Fig. 1). This vessel center-
line allows accurate measurement of the vessel length.5,6
The correlation between procedures planned using dedi-
cated imaging software and the reality of the intraoperative
procedure has been studied only in small cohorts.7 To date,
the impact of planning with 3D workstations on early and
midterm complications and secondary interventions after
EVAR has not been established.
MATERIAL AND METHODS
All patients treated for infrarenal abdominal aortic aneurysm
(AAA) using EVAR at our institution from January 2006 to
December 2009were included in the current study.This study
period was chosen to ensure a minimum 2-year follow-up
period for every patient and to eliminate potential inter-
fering variables such as the use of newer EVAR devices and
Figure 1. Interface of the Aquarius iNtuition Viewer. The software has semi-automatically generated a “centerline of ﬂow” (CLF); the aorta
has been longitudinally stretched along this CLF providing a curved planar reconstruction (CPR).
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prospectively collected database were analyzed retrospec-
tively. Two groups of patients were identiﬁed:
 Group 1 (non-3D workstation-assisted sizing): all patients
treated prior to January 2008, when preoperative aortic
anatomical measurements were performed using axial
CTA images only.
 Group 2 (3D workstation-assisted sizing): all patients
treated from January 2008, for whom CTA analysis and
endograft sizing was always performed with the use of
dedicated software on the 3D workstations.
All images were comparable: since 2005, all CTAs have
been performed at our institution using a 64-slice CT
scanner (Philips Brilliance 64 CT scanner, Philips Healthcare,
Amsterdam, the Netherlands). Triple-phase acquisition with
unenhanced and contrast-enhanced in arterial (with bolus-
tracking) and delayed phases (at 70 seconds) was carried
out from the thorax to the femoral bifurcations.
In group 1, preoperative aortic measurements for endog-
raft sizing were estimated by serial examination of the axial
CTA images.The axial diameters of the aorta at the level of the
lowest renal artery and 15 mm inferior of the aorto-iliac
bifurcation and the distal common iliac arteries were
measured. The longitudinal distances between the lower
margin of the lowest renal artery and the aorto-iliac bifur-
cation and also between the lower margin of the lowest renal
artery and both common iliac bifurcations were approxi-
mated by manual scrolling of the axial reconstructions, slice
counting, and knowledge of the slice thickness.Where there
was uncertainty, the longitudinal distances were conﬁrmed
peri-operatively by means of angiography using a graduated
intra-aortic measuring catheter (5-Fr Pigtail catheter).In group 2, the software used for reconstructions was the
Aquarius iNtuition Viewer (Aquarius, TeraRecon, San Mat-
teo, CA, USA). A “centerline of ﬂow” reconstruction using a
semi-automated centerline algorithm was generated to
assess the aortic morphology8 (Fig. 1). The centerline was
manually adjusted when necessary. Measurements included
the diameters of the aorta at the level of the lowest renal
artery and 15 mm lower, of the aorto-iliac bifurcation, and
of the distal common iliac arteries, the longitudinal dis-
tances between the lower margin of the lowest renal artery
and the aorto-iliac bifurcation and between the lower
margin of the lowest renal artery and both common iliac
arteries. The diameters measured in this group are the
maximal diameter measured within the orthogonal plane,
perpendicular to the centerline of ﬂow.
General details corresponding to patient characteristics,
anatomic measurements, and surgical data including the
type of the implanted endograft and supplementary pro-
cedures were collected.
Contrast-enhanced CTA was routinely performed prior to
hospital discharge. In patients with poor renal function,
contrast-free CT was associated with contrast-enhanced
ultrasound examination.9
Post-discharge follow-up included an ultrasound exami-
nation at 6 months and contrast-enhanced CTA associated
with plain abdominal radiography at 12 months; the last
two examinations were then repeated annually in the
absence of renal function impairment.
All postoperative complications and subsequent sec-
ondary interventions depicted during the 2-year period
following EVAR were collected according to the method
described by Chaikof et al.4 The delay between the initial
procedure and the postoperative complications was
noted.
Table 1. Demographics, comorbidities, and device speciﬁcs.
Group 1
(n ¼ 149)
Group 2
(n ¼ 146)
p Value
Age, years
(mean  SD)
72.77 (8.46) 72.81 (8.74) 0.968
Male 143 (96%) 139 (95%) 0.784
BMI (kg/m2) 28.25 (5.07) 27.54 (4.74) 0.244
420 J. Sobocinski et al.The 30-day mortality rate, the survival and freedom from
secondary intervention rates at 1, 2, and 3 years were
calculated for each group.
During the study period, the same two surgeons per-
formed all EVAR planning and implantations. Analysis of the
postoperative CTAs was performed by a senior vascular
radiologist.HBP 114 (76%) 112 (77%) 1
Type 2 diabetes 26 (17%) 26 (18%) 1
Coronary disease 63 (42%) 64 (44%) 0.81
COPD 61 (41%) 54 (37%) 0.55
Renal failure 22 (15%) 25 (17%) 0.63
Cardiac failure 4 (3%) 9 (6%) 0.16
Stroke 11 (7%) 18 (12%) 0.17
Device conﬁguration
Aorto-uni-iliac 27 (18%) 17 (12%) 0.14
Aorto-bi-iliac 122 (82%) 129 (88%) 0.14
Hypogastric
embolization
11 (7%) 11 (7%) 0.87
BMI ¼ body mass index; COPD ¼ chronic obstructive pulmonary
disease; HBP ¼ high blood pressure; SD ¼ standard deviation.
Table 2. Anatomic data (mm, mean  standard deviation).
Group 1 Group 2 p Value
AAA maximum diameter 58.7  11.2 58.2  10.6 0.244
Aortic diameter at the
level of the lowest
renal artery
25.4  3.6 23.5  3.2 0.123
Aortic diameter 15 mm
down to the lowest
renal artery
27.4  3.1 24.9  4.1 0.072
Infrarenal neck length 33.4  12.0 32.6  14.8 0.866
Common Iliac diameter
at sealing zone
15.4  2.8 15.8  3.1 0.708
Iliac sealing zone length 24.6  5.5 24.8  5.6 0.937
AAA ¼ abdominal aortic
aneurysm.Statistical analysis
Statistical analysis was performed using SPSS, version 20.0
(IBM Armonk, NY, USA).
Continuous variables are expressed as median with range
or mean  standard deviation (SD) and categorical data as
percentages.
Comparisons between groups were made with t tests or
ManneWhitney tests for continuous variables, and with
chi-square test for categorical variables.
Life tables according to the KaplaneMeier method were
conducted to estimate survival and freedom from second-
ary intervention rates, and differences were tested with the
log-rank test.
A p value <.05 was considered as statistically signiﬁcant.
RESULTS
Between January 2006 and December 2009, 326 patients
with AAA were treated in our institution using standard
commercially available endografts. Of these, 295 patients
(90.5%) had completed a minimum of 2 years of our
standard follow-up program and were included in the
current study. Prior to 2008 (group 1 ¼ 149 patients),
endograft sizing was performed by an analysis of the pre-
operative CTA axial cuts. After 2008 (group 2 ¼ 146 pa-
tients), endograft sizing was performed using a 3D
workstation (Aquarius, Terarecon). Out of the whole study
group, 251 (77.4%) received an aorto-bi-iliac endograft and
44 (22.6%) an aorto-uni-iliac device with supplementary
femoro-femoral bypass. A total of 287 Zenith (Cook Med-
ical, Bloomington, IN, USA) and eight Talent (Medtronic,
Minneapolis, MN, USA) endografts were implanted.
Tables 1 and 2 provide a summary of the preoperative
characteristics of each group. No signiﬁcant difference
(p > .05) was observed in these characteristics between
the groups.
Median follow-up was 41.5 months in group 1 (range
24.2e75.2 months) and 36.4 months in group 2 (range 24e
50.2 months) (p < .001), but this is accounted for by the
fact that the group 1 patients were operated on earlier than
the group 2 patients.
The 30-day mortality rate was 2.3% (2.0% in group 1,
2.7% in group 2; p ¼ .68).
The 1-year, 2-year, and 3-year estimated (KaplaneMeier
method) survival rates were respectively 92.6%, 86%, and
83% in group 1 and 90.4%, 85%, and 82% in group 2 (log-
rank, p ¼ .484) (Fig. 2A).
A total of 21 deaths were reported in each group
during the 2-year follow-up period, of which eight
were reported as being aneurysm related (Table 3). Therewas no statistically signiﬁcant difference between the
groups with respect to aneurysm or procedure related
deaths.
During the 2-year period following surgery, there were a
total of 44 postoperative complications: 27 in group 1 and
17 in group 2 (p ¼ .941). These postoperative complications
are detailed in Table 4. There was a signiﬁcantly higher rate
of type 1 endoleaks in group 1 (13 (8.7%) versus 2 (1.4%),
p ¼ .004). Secondary intervention rate for type 1 endoleak
in group 1 was consequently statistically more frequent
than in group 2 (p < .001) (Table 5). The rate of graft-
related complications was higher in group 1 (14.8% vs.
8.2%) but it did not reach statistical signiﬁcance (p ¼ .0784).
The overall (groups 1 and 2) freedom from secondary
intervention rate was 88.8% at 2 years (Fig. 2B). There was
no statistical difference between both groups in this regard
(86% in group 1 and 91% in group 2; p ¼ .617) despite less
secondary interventions performed in group 2.
The overall median time to secondary intervention was
17 months (range 0e23.3 months), with a median time of
18 months in group 1 and 15 months in group 2 (p ¼ .6).
Figure 2. Overall estimated survival (A) and freedom from sec-
ondary intervention estimated survival rates (KaplaneMeier
Method) (B).
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The clinical impact of sizing endografts with a 3D worksta-
tion for planning and performing EVAR had not previously
been critically evaluated. In our department, the ﬁrstTable 3. Aneurysm-related mortality during the 2-year period after en
Group 1 (n ¼ 149)
n %
Early mortality (30 days)
peri-operative hemorrhage 2 1.3
acute coronary syndrome 0 0
sepsis 1 0.7
Late mortality (>30 days)
sepsis 0 0
Total 3 2version of the Aquarius workstation was available towards
the close of 2007. We started using the 3D workstation for
all EVAR planning in routine practice in January 2008 hoping
to gain more information than was available using a “sim-
ple” CT scan analysis, by the addition of 3D reformatted CT
reconstructions.10
In this analysis, we decided to include only those patients
with a minimum 24-month follow-up in order to be able to
evaluate the impact of planning with a 3D workstation on
early and midterm outcomes. That EVAR is associated with a
higher secondary arterial intervention rate than open repair
has been widely reported.2 This might impair both patient
quality of life11 and EVAR cost-effectiveness.12,13 The
number of type 1 endoleaks and subsequent secondary
intervention rate was signiﬁcantly higher in group 1 (non-
assisted sizing) than in group 2 (3D workstation-assisted
sizing). In the EVAR1 trial, the type 1 endoleak (some
associated with proximal endograft migration) rate was
8.1% (43 in 529 patients),14 which is similar to group 1 in
this report. The 2-year survival rates (86% in group 1 and
85% in group 2) of our cohort are broadly similar to those
reported in the EVAR and DREAM trials.14,15
Type 1 endoleaks are high-ﬂow and high-pressure endo-
leaks and usually require secondary intervention.16 They
result from poor endograft sizing (diameter and/or sealing
zone length) or adverse aortic anatomy (i.e. aneurysm neck
anatomy unsuitable for EVAR).4,17 Our study shows clinical
evidence that software-assisted sizing is associated with
reductions in the incidence of type 1 endoleaks (p ¼ .004)
and their related secondary interventions (p < .001). One
previous retrospective study has already demonstrated that
the use of a software-assisted centerline (using PEMS,
Medical Media System, West Lebanon, NH, USA) reduces
the use of unplanned iliac extensions in EVAR procedures.7
The implantation of an infrarenal aortic endoprosthesis is
a relatively simple procedure. Its execution requires pre-
operative length and diameter measurements and then
accurate longitudinal device placement. Essential informa-
tion needed for the preoperative assessment of an aortic
aneurysm includes the relationship of the aneurysm to the
aortic branches, the degree of iliac arterial involvement by
the aneurysm, the presence of other coexisting iliac arterial
or aortic aneurysms, the presence of supernumerary or
aberrant aortic branches, and the presence of coexistent
iliac arterial occlusive disease. Software designed to assist
EVAR planning using 3D workstations have been developeddovascular treatment of abdominal aortic aneurysm.
Group 2 (n ¼ 146) p Value
n %
0 0
2 1.4
1 0.7
2 1.4
5 3.4 0.45
Table 4. All complications depicted during the 2-year period after endovascular treatment of abdominal aortic aneurysm.
Group 1 (n ¼ 149) Group 2 (n ¼ 146) p Value
n % n %
Type 1 endoleaks 13 8.7 2 1.4 0.004
1a (proximal) 6 4.0 0 0 0.01
1b (distal) 7 4.7 2 1.4 0.097
Type 3 endoleaks 2 1.3 1 0.7 a
Type 2 endoleaks requiring embolization 2 1.3 2 1.4 a
Limb kinking or thrombosis 5 3.3 7 4.8 0.529
All above graft-related complications 22 14.8 12 8.2 0.0784
Renal artery malperfusion 1 0.7 0 0
Ischemic colitis 1 0.7 0 0
Aneurysm related mortality 3 2.0 5 3.4 0.45
Total 27 18.1 17 11.6 0.144
a When the number of events was less than 5, the p value was considered as not relevant.
Table 5. Secondary Interventions during the ﬁrst 2 years of follow-up.
Group 1 (n ¼ 149) Group 2 (n ¼ 146) p Value
n % n %
Type 1 endoleak 8 5.4 0 0 <.001
1a (proximal)a 4 0 c
1b (distal)b 4 0 c
Type 3 endoleak 0 0 1 0.7 c
Type 2 endoleak 2 1.3 3 2 c
Limb kinking or thrombosis 5 3.3 7 4.8 .529
Femoral Access repair 3 2 1 0.7 c
Ischemic colitis 1 0.7 0 0 c
Renal artery stenting 1 0.7 0 0 c
Total 18 12.1 12 8.2 .271
a Proximal aortic cuff extension.
b Distal limb extension.
c When the number of events was less than 5, the p value was considered as not relevant.
422 J. Sobocinski et al.during the past 10 years. On currently available 3D work-
stations, automated and semi-automated vessel analysis
tools are integrated in the software. The generation of a
centerline of ﬂow image (Fig. 1) allows the visualization of a
tortuous aorta as though it were straightened and greatly
aids in the design of the endoprosthesis, particularly in
accurately measuring the correct length of the graft be-
tween key anatomic targets such as branch locations and
vessel bifurcations.5,6,18 Nevertheless, a degree of judgment
by the planner/operator is required.
Multidetector row CT and 3D workstation analysis have
now replaced the old “gold standard” intra-arterial digital
subtraction angiography for assessing (the length of)
abdominal, thoracic, and cranial vasculature. 3D worksta-
tions are now intuitive and “user-friendly”, which makes
them accessible to vascular surgeons and radiologists alike.
The results from our study demonstrate that these tools are
mandatory in everyday practice to enhance mid-term EVAR
results.
In addition to the study design (retrospective analysis of
prospectively collected data), we acknowledge the following
study limitations. This study reports the experience of a
single high-volume center dedicated to aortic endografting.
We believe that there was no bias in our inclusion criteria
for EVAR during the study period because our experiencewith custom-made fenestrated and branched aortic
endografts (FEVAR) started in 2005. Thus, during the study
period, all patients with unfavorable infrarenal neck anat-
omies had either open repair or FEVAR if they were deemed
unﬁt for open surgery. We have strictly followed the
anatomical inclusion criteria for infrarenal standard EVAR
reported by the European Society for Vascular Surgery
guidelines and Chaikof et al.4 and Moll et al.19
In conclusion, the routine use of 3DWS for EVAR planning
signiﬁcantly reduces the rate of type 1 endoleaks. Access to
these workstations is mandatory to enhance current results
of EVAR.FUNDING
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